Purchase Order 75N91024P00461

Award Date 7/1/24
Potential Completion Date 9/30/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) has awarded a $31,100 firm-fixed-price purchase order to Miltenyi Biotec, Inc. for the procurement of one Miltenyi Biotec GentleMACS Octo Dissociator with Heating Units. This equipment will be used in support of the Laboratory of Tumor Immunology and Biology (LTIB) at the Center for Immuno-Oncology (CIO) within the NCI's Center for Cancer Research (CCR). The contract has an ultimate completion date of September 30, 2024. Miltenyi Biotec is a global...
This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of an AUTOMACS Pro Separator Instrument. The $36,906.00 contract has an ultimate completion date of August 8, 2013. Miltenyi Biotec has extensive experience as a prime contractor for the NIH, Department of Veterans Affairs, and other federal agencies,...
This is a $13,092 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a SERVICE CONTRACT FOR AUTOMACS PRO SEPARATOR with a completion date of December 14, 2020. Miltenyi Biotec, a global biotechnology company, has served as a prime contractor on numerous contracts with federal agencies,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,750 purchase order to Miltenyi Biotec, Inc. to provide service agreement support from November 2023 through November 2024. As a prime contractor, Miltenyi Biotec will deliver services to assist the National Cancer Institute in advancing its mission of cancer research and treatment. The contract has a firm fixed price and will be performed in Bethesda, Maryland. No set aside...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $120,526.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, for the acquisition of a Miltenyi MACSQuant 10 Analyzer. The equipment will be used at the NIH campus in Bethesda, Maryland. Miltenyi Biotec has extensive experience providing scientific instruments, reagents, and cell therapy manufacturing platforms to federal...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $5,550 contract is for the maintenance plan and service agreement for an AutoMACS Pro Separator, a specialized cell separation instrument. Miltenyi Biotec is a prime contractor with extensive experience providing a range of cell processing equipment, reagents, and...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Miltenyi Biotec, Inc., a global biotechnology company, for the provision of two AUTOMACS Pro Separators. The $12,598.00 firm fixed-price purchase order contract has a completion date of December 14, 2018. Miltenyi Biotec specializes in scientific instruments, cell separation technology, and services supporting cell and gene...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $80,180.00 firm fixed price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the delivery of AutoMACS NEO separators and MACS MiniSampler instruments. The contract has an ultimate completion date of December 10, 2024. This contract is not associated with a larger contract vehicle, and there is no set-aside designation. Miltenyi Biotec is a global biotechnology...

The National Cancer Institute (NCI) awarded a $55,190.00 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc. for the procurement of one Miltenyi Biotec autoMACS NEO Separator and MACS MiniSampler S. This equipment will support the Clinical Immunotherapy Section of the Laboratory of Molecular Biology at the NCI's Center for Cancer Research. The contract has an ultimate completion date of September 30, 2024 and was awarded on July 1, 2024. This purchase order was not set aside for any socioeconomic program. Miltenyi Biotec, Inc. is a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research, cell therapy development, and clinical translation. The company has extensive experience as a federal contractor, supporting numerous agencies including the NIH, VA, FDA, DoD, CDC, and USDA.

Generated 8/14/24, 9:54 AM